title: What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?
abstract: Cortisol is an essential stress hormone and replacement with oral hydrocortisone is lifesaving in patients with adrenal insufficiency. Cortisol has a diurnal rhythm regulated by the central body clock and this rhythm is a metabolic signal for peripheral tissue clocks. Loss of cortisol rhythmicity is associated with fatigue, depression and insulin resistance. A general principle in endocrinology is to replace hormones to replicate physiological concentrations; however, the pharmacokinetics of oral immediate-release hydrocortisone make it impossible to fully mimic the cortisol rhythm and patients still have an increased morbidity and mortality despite replacement. Traditionally, physicians have replaced hydrocortisone with a total daily dose based on the diurnal 24-h cortisol production rate with hydrocortisone given twice or thrice daily, with the highest dose first thing in the morning. Monitoring treatment and dose titration has been much debated with some clinicians using cortisol day curves and others relying on clinical symptoms. The main challenge is that there is no established biomarker of cortisol activity. In addressing the clinical question, we have taken the view that an understanding of the cortisol circadian rhythm and hydrocortisone pharmacokinetics is essential when tailoring hydrocortisone dose. Using this approach, we have developed a thrice daily, weight-related, dosing regimen and a pharmacokinetic and clinical method to monitor treatment. Our argument for replicating the cortisol circadian rhythm is based on the observation that disruption of the rhythm is associated with ill health, and the few studies that have compared different treatment regimens. Further studies are required to definitively test the benefits of replacing the cortisol circadian rhythm in patients with adrenal insufficiency.
authors.affiliation: Academic Unit of Diabetes, Endocrinology and Reproduction, University of Sheffield, Sheffield, UK.
authors.forename: Miguel
authors.initials: M
authors.lastname: Debono
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Ross
mesh_terms: D000309:Adrenal Insufficiency / Q000188:drug therapy* / Q000378:metabolism; D002940:Circadian Rhythm; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use*
chemical_list: D006854:Hydrocortisone